Surgery Partners (SGRY) Stock Forecast, Price & News

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

Is Surgery Partners a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Surgery Partners stock.
View analyst ratings for Surgery Partners or view top-rated stocks.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Surgery Partners.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings results on Tuesday, May, 3rd. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.02. Surgery Partners had a negative trailing twelve-month return on equity of 0.46% and a negative net margin of 1.63%. During the same quarter in the prior year, the firm earned ($0.40) earnings per share.
View Surgery Partners' earnings history.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.50 billion-$2.60 billion, compared to the consensus revenue estimate of $2.53 billion.

What price target have analysts set for SGRY?

6 analysts have issued 1-year target prices for Surgery Partners' shares. Their forecasts range from $50.00 to $73.00. On average, they anticipate Surgery Partners' share price to reach $61.88 in the next year. This suggests a possible upside of 56.0% from the stock's current price.
View analysts' price targets for Surgery Partners or view top-rated stocks among Wall Street analysts.

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:

• Mr. Wayne Scott DeVeydt, Exec. Chairman (Age 52, Pay $500k)
• Mr. J. Eric Evans, CEO & Director (Age 45, Pay $1.81M)
• Ms. Jennifer B. Baldock, Exec. VP and Chief Admin. & Devel. Officer (Age 51, Pay $888.1k) (LinkedIn Profile)
• Mr. Anthony W. Taparo, Chief Growth Officer (Age 56, Pay $751.84k) (LinkedIn Profile)
• Mr. Bradley R. Owens, Pres of National Group (Age 52, Pay $788.72k)
• Mr. David T. Doherty, Exec. VP & CFO (Age 50)
• Mr. Varun Gadhok, Sr. VP & Chief Information Officer
• Ms. Roxanne Womack, Sr. VP & Chief Compliance Officer
• Ms. Laura L. Brocklehurst, Sr. VP & Chief HR Officer (Age 52) (LinkedIn Profile)
• Mr. George M. Goodwin, Pres of ASC Group (Age 61) (LinkedIn Profile)

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners CEO Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among Surgery Partners' employees.

Who are some of Surgery Partners' key competitors?

Some companies that are related to Surgery Partners include Universal Health Services (UHS), Tenet Healthcare (THC), Community Health Systems (CYH), Rennova Health (RNVAD), First Physicians Capital Group (FPCG), SunLink Health Systems (SSY), SunLink Health Systems (SSY), Ethema Health (GRST) and Rennova Health (RNVA).
View all of SGRY's competitors.

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR).

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (4.54%), Vanguard Group Inc. (4.10%), BlackRock Inc. (2.54%), Durable Capital Partners LP (2.13%), Invesco Ltd. (1.72%) and Victory Capital Management Inc. (1.49%). Company insiders that own Surgery Partners stock include Anthony Taparo, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends for Surgery Partners.

Which institutional investors are selling Surgery Partners stock?

SGRY stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Dimensional Fund Advisors LP, Victory Capital Management Inc., Royal Bank of Canada, Simplex Trading LLC, TD Asset Management Inc., Northern Trust Corp, and UBS Group AG. Company insiders that have sold Surgery Partners company stock in the last year include Anthony Taparo, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Teresa Deluca, and Wayne S Deveydt.
View insider buying and selling activity for Surgery Partners or view top insider-selling stocks.

Which institutional investors are buying Surgery Partners stock?

SGRY stock was acquired by a variety of institutional investors in the last quarter, including Durable Capital Partners LP, Calamos Advisors LLC, Hood River Capital Management LLC, Pier Capital LLC, First Trust Advisors LP, Sivik Global Healthcare LLC, Cannell & Co., and Clearbridge Investments LLC.
View insider buying and selling activity for Surgery Partners or or view top insider-buying stocks.

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $39.66.

How much money does Surgery Partners make?

Surgery Partners has a market capitalization of $3.57 billion and generates $2.23 billion in revenue each year. The company earns $-70.90 million in net income (profit) each year or ($0.53) on an earnings per share basis.

How many employees does Surgery Partners have?

Surgery Partners employs 10,900 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is www.surgerypartners.com.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at (615) 234-5900, via email at [email protected], or via fax at 615-234-5998.